Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Allan M. Arbeter"'
Publikováno v:
Pediatrics. 96:216-219
Objective. To evaluate the effectiveness in low birth weight (LBW) infants of the currently recommended immunization schedule for conjugated Haemophilus influenzae type b (HIB) vaccine. Methods. We quantified antibody responses in 36 preterm infants
Autor:
Allan M. Arbeter, Linda Granowetter, Stuart E. Starr, Beverly Lange, Robert Wimmer, Stanley A. Plotkin
Publikováno v:
Pediatrics. 85:338-344
A total of 44 children with acute lymphoblastic leukemia were immunized against chickenpox with the Oka/Merck strain live attenuated varicella vaccine. Of these children, 24 continued oral chemotherapy with 6-mercaptopurine during the immunization pe
Autor:
A Ngai, Allan M. Arbeter, Mary L. Kumar, Keith S. Reisinger, Henry H. Bernstein, C. Jo White, Mark M. Blatter, Barbara Watson, Stephen A. Chartrand, Edward P. Rothstein, Dennis A. Clements, Ann M. Arvin, Brenda Staehle, Stuart E. Starr
Publikováno v:
Journal of Infectious Diseases. 172:217-219
Four hundred nineteen children and adolescents immunized with live varicella vaccine 4-6 years earlier were enrolled in a study to evaluate the safety and immune response to a booster dose containing approximately 3300 pfu of virus. Of the subjects,
Autor:
Henry H. Bernstein, Edward P. Rothstein, Pennridge Pediatric Associates, Michael E. Pichichero, John L. Green, Elmwood Pediatrics, Keith S. Reisinger, Mark M. Blatter, Judith Halpern, Allan M. Arbeter, David I. Bernstein, Vicki Smith, Sarah S. Long, Hal Rathfon, David S. Krause
Publikováno v:
Vaccine. 13(17)
Five hundred and fifty-seven infants received either an acellular pertussis (DTaP) vaccine containing pertussis toxoid (PT), filamentous hemagglutinin (FHA) and pertactin (PRN) or one of two commercially available whole-cell pertussis (DTP) vaccines
Publikováno v:
Journal of Interferon Research. 3:263-269
Pretreatment of normal adult peripheral blood mononuclear cells with interferon-α (IFN-α) resulted in enhanced natural killing (NK) of varicella-zoster virus (VZV)-infected and uninfected target ce...
Autor:
Inara Orr, Allan M. Arbeter, Marlene K Stahl, Elliot F. Ellis, Kenneth McIntosh, David S. Hodes
Publikováno v:
Pediatric Research
Extract: Two live “attenuated” respiratory syncytial virus (RSV) vaccines were administered intranasally and by aerosol in placebo-controlled trials among asthmatic children hospitalized at National Jewish Hospital and Research Center (NJH). The
Publikováno v:
The Journal of Pediatrics. 103:131-135
The elimination pharmacokinetics of tobramycin sulfate was studied in 25 newborn infants of birth weight 0.7 to 4.7 kg during 31 treatment episodes. The peak serum concentrations after a 2.5 mg/kg dose were usually within the therapeutic range of 5 t
Publikováno v:
The Journal of Pediatrics. 100:886-893
Ninety-one healthy children were immunized with one of three preparations of the OKA strain of live attenuated varicella zoster virus in order to gain sufficient information on safety and immunogenicity to justify vaccine studies in immunosuppressed
Publikováno v:
Pediatrics. 71:307-312
The KMcC strain of live, attenuated varicella-zoster virus vaccine was studied in healthy children as a preliminary step toward varicella vaccine studies with this strain in children with leukemia. Forty-three children were immunized: 26 with the 40t
Publikováno v:
Pediatrics International. 31:523-528
We studied mononuclear cell (MNC)-mediated natural killing (NK) of varicella-zoster virus (VZV)-infected fibroblasts in normal children, children with VZV infections, and children with Hodgkin's disease. NK activity was tested in 18 hr 51Cr release a